PM says life sciences is a key partner to fixing the NHS

In his speech today, the Prime Minister has committed to putting the full weight of the British government behind life sciences as part of his plan to fix the NHS.

At The Kings Fund annual conference today, the Prime Minister stressed the UK's poor performance in avoidable and preventable mortality.[1] He highlighted the need to tackle the increasing levels of sickness in society as a means of raising productivity, as well as reducing pressures on the NHS. Making better use of innovative medicines and vaccines must be part of this picture.

In the speech, he also said he would put “the full weight of the British government behind our world-leading life sciences”, making the industry a key partner in his plans to improve UK health outcomes while also supporting economic growth.

Responding, Richard Torbett, Chief Executive of the ABPI said: “The Darzi review made sobering reading, but there is now a huge opportunity in this moment to move forward. Innovation lies at the heart of the solution to the NHS’s problems, and innovation is at the core of the UK’s life sciences sector.

“Cutting-edge science and industry clinical trials can and do support the NHS to improve patients’ health outcomes. Together, we can create a healthier, more productive population and help address the pressures the NHS faces.

“That’s why the Prime Minister is right to throw the weight of government behind our world-leading life sciences sector. We can’t wait to throw our weight behind the NHS’s, and society’s, recovery.”

TAGS
  • NHS

Last modified: 12 September 2024

Last reviewed: 12 September 2024

[1] The King’s Fund, commissioned by the ABPI, How does the NHS compare to the health care systems of other countries?, June 2023, available at https://assets.kingsfund.org.uk/f/256914/x/7cdf5ad1de/how_nhs_compares_other_countries_abpi_2023.pdf

The ABPI exists to make the UK the best place in the world to research, develop and use new medicines. We represent companies of all sizes who invest in discovering the medicines of the future. 

Our members supply cutting edge treatments that improve and save the lives of millions of people. We work in partnership with Government and the NHS so patients can get new treatments faster and the NHS can plan how much it spends on medicines. Every day, we partner with organisations in the life sciences community and beyond to transform lives across the UK.